Review Article
Intravenous Iron Administration and Hypophosphatemia in Clinical Practice
Table 2
Comparison between patients developing hypophosphatemia after FCM injection and patients without hypophosphatemia.
| | Patients with hypophosphatemia | Patients without hypophosphatemia | |
| | 38 | 40 | | Women/men | 27/11 | 27/13 | NS | Age | 57 ± 11 | 58 ± 19 | NS | Vitamin D level before injection (ng/mL) | 21.9 ± 16.9 | 20 ± 10 | NS | Hemoglobin (g/L) | 9.5 ± 1.3 | 9.7 ± 1.8 | NS | Ferritin (µg/L) | 44 (6.25–55) | 80 (9–95) | | Cumulated dose (mg) | 2092 ± 2002 | 1350 ± 860 | |
|
|